Montaña Caballero Bermejo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Montaña Caballero Bermejo has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Annette Eva Langkilde
Department of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark
2 shared publications - Antoni Kowalski
Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark
2 shared publications - Birthe Brandt Kragelund
REPIN, Department of Biology, University of Copenhagen, Copenhagen N, Denmark
2 shared publications - Emil Gregersen
Danish Research Institute of Translational Neuroscience - DANDRITE, Aarhus University, Aarhus, Denmark
2 shared publications - Estella Anne Newcombe
REPIN, Department of Biology, University of Copenhagen, Copenhagen N, Denmark
2 shared publications - Francisco Centeno
Departamento de Bioquímica y Biología Molecular, Facultad de Veterinaria, Universidad de Extremadura, Cáceres, Spain
2 shared publications
Latest Publications
- Open Access
- 2 November 2023
- Published by Springer Nature in The EMBO Journal
- Vol. 42 (23) , e111122
Monomeric α‐synuclein activates the plasma membrane calcium pump
Alpha‐synuclein (aSN) is a membrane‐associated and intrinsically disordered protein, well known for pathological aggregation in neurodegeneration. However, the physiological function of aSN is disputed. Pull‐down experiments have pointed to plasma membrane Ca 2+ ‐ATPase (PMCA) as a potential interaction partner. From proximity ligation assays, we find that aSN and PMCA colocalize at neuronal synapses, and we show that calcium expulsion is activated by aSN and PMCA. We further show that soluble, monomeric aSN activates PMCA at par with calmodulin, but independent of the autoinhibitory domain of PMCA, and highly dependent on acidic phospholipids and membrane‐anchoring properties of aSN. On PMCA, the key site is mapped to the acidic lipid‐binding site, located within a disordered PMCA‐specific loop connecting the cytosolic A domain and transmembrane segment 3. Our studies point toward a novel physiological role of monomeric aSN as a stimulator of calcium clearance in neurons through activation of PMCA.
- 2 November 2023
- Published by Springer Nature in The EMBO Journal
- Vol. 42 (23) , e111122
Open AccessMonomeric α‐synuclein activates the plasma membrane calcium pump
Alpha‐synuclein (aSN) is a membrane‐associated and intrinsically disordered protein, well known for pathological aggregation in neurodegeneration. However, the physiological function of aSN is disputed. Pull‐down experiments have pointed to plasma membrane Ca 2+ ‐ATPase (PMCA) as a potential interaction partner. From proximity ligation assays, we find that aSN and PMCA colocalize at neuronal synapses, and we show that calcium expulsion is activated by aSN and PMCA. We further show that soluble, monomeric aSN activates PMCA at par with calmodulin, but independent of the autoinhibitory domain of PMCA, and highly dependent on acidic phospholipids and membrane‐anchoring properties of aSN. On PMCA, the key site is mapped to the acidic lipid‐binding site, located within a disordered PMCA‐specific loop connecting the cytosolic A domain and transmembrane segment 3. Our studies point toward a novel physiological role of monomeric aSN as a stimulator of calcium clearance in neurons through activation of PMCA.
- Open Access
Monomeric α-Synuclein activates the Plasma Membrane Calcium Pump
Alpha-synuclein (aSN) is a membrane-associated and intrinsically disordered protein, well-known for pathological aggregation in neurodegeneration. The physiological function of aSN however is disputed. Pull-down experiments have pointed to plasma membrane Ca 2+ -ATPase (PMCA) as a potential interaction partner. From proximity ligation assays we find that aSN and PMCA colocalize at neuronal synapses, and that calcium expulsion is activated by aSN and PMCA. From PMCA activity studies we show that soluble, monomeric aSN activates PMCA at par with CaM, yet independent of the autoinhibitory domain of PMCA, but highly dependent on acidic phospholipids and membrane-anchoring of aSN. On PMCA, the key site is mapped to the acidic lipid-binding site, located within a disordered PMCA-specific loop region connecting the cytosolic A domain and transmembrane segment 3. Our studies point towards a novel physiological role of monomeric aSN as a stimulator of calcium clearance in neurons through activation of PMCA.
Open AccessMonomeric α-Synuclein activates the Plasma Membrane Calcium Pump
Alpha-synuclein (aSN) is a membrane-associated and intrinsically disordered protein, well-known for pathological aggregation in neurodegeneration. The physiological function of aSN however is disputed. Pull-down experiments have pointed to plasma membrane Ca 2+ -ATPase (PMCA) as a potential interaction partner. From proximity ligation assays we find that aSN and PMCA colocalize at neuronal synapses, and that calcium expulsion is activated by aSN and PMCA. From PMCA activity studies we show that soluble, monomeric aSN activates PMCA at par with CaM, yet independent of the autoinhibitory domain of PMCA, but highly dependent on acidic phospholipids and membrane-anchoring of aSN. On PMCA, the key site is mapped to the acidic lipid-binding site, located within a disordered PMCA-specific loop region connecting the cytosolic A domain and transmembrane segment 3. Our studies point towards a novel physiological role of monomeric aSN as a stimulator of calcium clearance in neurons through activation of PMCA.
- Open Access
- 18 July 2019
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (14) , 3521
Methylene Blue Blocks and Reverses the Inhibitory Effect of Tau on PMCA Function
Methylene blue (MB) is a synthetic phenothiazine dye that, in the last years, has generated much debate about whether it could be a useful therapeutic drug for tau-related pathologies, such as Alzheimer’s disease (AD). However, the molecular mechanism of action is far from clear. Recently we reported that MB activates the plasma membrane Ca2+-ATPase (PMCA) in membranes from human and pig tissues and from cells cultures, and that it could protect against inactivation of PMCA by amyloid β-peptide (Aβ). The purpose of the present study is to further examine whether the MB could also modulate the inhibitory effect of tau, another key molecular marker of AD, on PMCA activity. By using kinetic assays in membranes from several tissues and cell cultures, we found that this phenothiazine was able to block and even to completely reverse the inhibitory effect of tau on PMCA. The results of this work point out that MB could mediate the toxic effect of tau related to the deregulation of calcium homeostasis by blocking the impairment of PMCA activity by tau. We then could conclude that MB could interfere with the toxic effects of tau by restoring the function of PMCA pump as a fine tuner of calcium homeostasis.
- 18 July 2019
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (14) , 3521
Open AccessMethylene Blue Blocks and Reverses the Inhibitory Effect of Tau on PMCA Function
Methylene blue (MB) is a synthetic phenothiazine dye that, in the last years, has generated much debate about whether it could be a useful therapeutic drug for tau-related pathologies, such as Alzheimer’s disease (AD). However, the molecular mechanism of action is far from clear. Recently we reported that MB activates the plasma membrane Ca2+-ATPase (PMCA) in membranes from human and pig tissues and from cells cultures, and that it could protect against inactivation of PMCA by amyloid β-peptide (Aβ). The purpose of the present study is to further examine whether the MB could also modulate the inhibitory effect of tau, another key molecular marker of AD, on PMCA activity. By using kinetic assays in membranes from several tissues and cell cultures, we found that this phenothiazine was able to block and even to completely reverse the inhibitory effect of tau on PMCA. The results of this work point out that MB could mediate the toxic effect of tau related to the deregulation of calcium homeostasis by blocking the impairment of PMCA activity by tau. We then could conclude that MB could interfere with the toxic effects of tau by restoring the function of PMCA pump as a fine tuner of calcium homeostasis.
- 1 December 2017
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 636, 42-49
JNK signaling pathway regulates sorbitol-induced Tau proteolysis and apoptosis in SH-SY5Y cells by targeting caspase-3
- 1 December 2017
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 636, 42-49
JNK signaling pathway regulates sorbitol-induced Tau proteolysis and apoptosis in SH-SY5Y cells by targeting caspase-3
- 5 May 2016
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 117 (12) , 2781-2790
Hyperosmotic Stress Induces Tau Proteolysis by Caspase‐3 Activation in SH‐SY5Y Cells
Tau is a microtubule‐associated protein implicated in the pathogenesis of Alzheimer's disease and other related tauopathies. In this subset of neurodegenerative disorders, Tau auto‐assembles into insoluble fibrils that accumulate in neurons as paired helical filaments (PHFs), promoting cellular dysfunction and cytotoxic effects. Growing evidence suggests that abnormal post‐translational regulation, mainly hyperphosphorylation and aberrant cleavage, drives Tau to this pathological state. In this work we show that sorbitol‐induced hyperosmotic stress promotes Tau proteolysis in SH‐SY5Y neuroblastoma cells. The appearance of cleaved Tau was preceded by the activation of μ‐calpain, the proteasome system and caspase‐3. Tau proteolysis was completely prevented by caspase‐3 inhibition but unaffected by neither the proteasome system nor μ‐calpain activity blockade. Concomitantly, hyperosmotic stress induced apoptosis in SH‐SY5Y cells, which was efficiently avoided by the inhibition of caspase‐3 activity. Altogether, our results provide the first evidence that Tau protein is susceptible to caspase‐3 proteolysis under hyperosmotic stress and suggest a positive relationship between Tau proteolysis and apoptosis in SH‐SY5Y cells. J. Cell. Biochem. 117: 2781–2790, 2016.
- 5 May 2016
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 117 (12) , 2781-2790
Hyperosmotic Stress Induces Tau Proteolysis by Caspase‐3 Activation in SH‐SY5Y Cells
Tau is a microtubule‐associated protein implicated in the pathogenesis of Alzheimer's disease and other related tauopathies. In this subset of neurodegenerative disorders, Tau auto‐assembles into insoluble fibrils that accumulate in neurons as paired helical filaments (PHFs), promoting cellular dysfunction and cytotoxic effects. Growing evidence suggests that abnormal post‐translational regulation, mainly hyperphosphorylation and aberrant cleavage, drives Tau to this pathological state. In this work we show that sorbitol‐induced hyperosmotic stress promotes Tau proteolysis in SH‐SY5Y neuroblastoma cells. The appearance of cleaved Tau was preceded by the activation of μ‐calpain, the proteasome system and caspase‐3. Tau proteolysis was completely prevented by caspase‐3 inhibition but unaffected by neither the proteasome system nor μ‐calpain activity blockade. Concomitantly, hyperosmotic stress induced apoptosis in SH‐SY5Y cells, which was efficiently avoided by the inhibition of caspase‐3 activity. Altogether, our results provide the first evidence that Tau protein is susceptible to caspase‐3 proteolysis under hyperosmotic stress and suggest a positive relationship between Tau proteolysis and apoptosis in SH‐SY5Y cells. J. Cell. Biochem. 117: 2781–2790, 2016.